We provide funding support to ensure promising targets are investigated, and researchers see male contraception as a viable field of scientific enquiry.
Funding Highlight
|
Male Contraceptive Initiative's Fellowship Program
Our Fellowship program provides direct research support to graduates and postdoctoral fellows investigating novel ways of developing or supporting male contraceptives. This program is a critical component of our funding strategy as it helps to ensure promising, talented scientific minds stay engaged in the field, and that they receive the support and mentorship necessary to achieve success. Find additional details below! |
|
On this page we feature information about our funding schemes, links to internal and external announcements, and contact information. Most new research projects are funded through our annual funding cycle that generally opens in early Q2. We also have opportunities for trainee support, including an annual graduate and postdoctoral fellowship program that opens in late Q1. Please see additional details in the below sections.
Current MCI Research Funding
Grants & Program-related Investments
There are no currently active calls for MCI research grants, but please be sure to monitor this page for future funding opportunities in 2023. For reference purposes, and to assist prospective applicants for future awards, please see the 2022 funding announcement:
There are no currently active calls for MCI research grants, but please be sure to monitor this page for future funding opportunities in 2023. For reference purposes, and to assist prospective applicants for future awards, please see the 2022 funding announcement:
-------------------------
MCI-BCM Sponsored Target Screening
This opportunity will facilitate the screening of validated male contraceptive targets for small-molecule inhibitors using the DNA-Encoded Chemistry Technology (DEC-Tec) core facilities available in the lab of Dr. Martin Matzuk and Center for Drug Discovery at Baylor College of Medicine (BCM). The purpose of this opportunity is to allow investigators with validated male contraceptive targets to utilize state-of-the-art screening facilities to identify “hit” molecules that bind to the target of interest.
We are now accepting applications for the MCI-BCM Sponsored Target Screening Award. Please see the application announcement for details, and reach out to us with any questions.
This opportunity will facilitate the screening of validated male contraceptive targets for small-molecule inhibitors using the DNA-Encoded Chemistry Technology (DEC-Tec) core facilities available in the lab of Dr. Martin Matzuk and Center for Drug Discovery at Baylor College of Medicine (BCM). The purpose of this opportunity is to allow investigators with validated male contraceptive targets to utilize state-of-the-art screening facilities to identify “hit” molecules that bind to the target of interest.
We are now accepting applications for the MCI-BCM Sponsored Target Screening Award. Please see the application announcement for details, and reach out to us with any questions.
-------------------------
For information about future grant opportunities please reach out to grants@malecontraceptive.org, and be sure to subscribe to our newsletter at the bottom of this page in order to be notified of the latest Male Contraceptive Initiative funding opportunities!
MCI's Trainee & Youth Funding Opportunities
Trainee Fellowships
Male Contraceptive Initiative supports a fellowship program for graduate students and postdoctoral trainees working with senior investigators in the field of male contraceptives. Our 2022 Fellowship cycle has closed. Please watch this space for future opportunities or reach out to us at grants@malecontraceptive.org with any questions.
Male Contraceptive Initiative supports a fellowship program for graduate students and postdoctoral trainees working with senior investigators in the field of male contraceptives. Our 2022 Fellowship cycle has closed. Please watch this space for future opportunities or reach out to us at grants@malecontraceptive.org with any questions.
-------------------------
Trainee Success Program
MCI supports the career development of graduate and postdoctoral trainees directly through our Success program. Applications are accepted on a rolling basis for any activity or need that advances the career of a trainee interested in the field of male contraception. Examples of eligible activities include travel grants, digital conferences, workshops, and other professional development opportunities. Applications are evaluated based on relevance of the proposed activity, applicant strength and available funds. Applicants are encouraged to contact grants@malecontraceptive.org for questions regarding eligibility.
MCI supports the career development of graduate and postdoctoral trainees directly through our Success program. Applications are accepted on a rolling basis for any activity or need that advances the career of a trainee interested in the field of male contraception. Examples of eligible activities include travel grants, digital conferences, workshops, and other professional development opportunities. Applications are evaluated based on relevance of the proposed activity, applicant strength and available funds. Applicants are encouraged to contact grants@malecontraceptive.org for questions regarding eligibility.
-------------------------
The Beverly Tucker Award
Beverly Tucker, MPH, MPIA, PMP, is a founding board member of Male Contraceptive Initiative and has an illustrious career in global health spanning decades, as well as continents. She is a champion for male contraception, and passionate about supporting scientists all over the world. The annual Tucker Award was established in 2020 to support professional development in the setting of international health. Male Contraceptive Initiative’s Beverly Tucker Award provides up to $5,000 to support a student or professional residing outside of the United States to travel internationally for the purposes of career development. We are currently accepting applications for the Tucker Award. Please see the application details for more information, or reach out to us with any questions at grants@malecontraceptive.org.
Beverly Tucker, MPH, MPIA, PMP, is a founding board member of Male Contraceptive Initiative and has an illustrious career in global health spanning decades, as well as continents. She is a champion for male contraception, and passionate about supporting scientists all over the world. The annual Tucker Award was established in 2020 to support professional development in the setting of international health. Male Contraceptive Initiative’s Beverly Tucker Award provides up to $5,000 to support a student or professional residing outside of the United States to travel internationally for the purposes of career development. We are currently accepting applications for the Tucker Award. Please see the application details for more information, or reach out to us with any questions at grants@malecontraceptive.org.
-------------------------
MCI's Youth Advisory Board Undergraduate Project Grant
MCI's Youth Advisory Board (YAB) is a group of young people (ages 16-28) providing their perspectives to our work and advocating for male contraception. This request for applications is for undergraduate students interested in working on projects related to new male contraception. Applications for the 2022 grant are now closed, but those interested in learning more are encouraged to contact grants@malecontraceptive.org for questions regarding future opportunities.
MCI's Youth Advisory Board (YAB) is a group of young people (ages 16-28) providing their perspectives to our work and advocating for male contraception. This request for applications is for undergraduate students interested in working on projects related to new male contraception. Applications for the 2022 grant are now closed, but those interested in learning more are encouraged to contact grants@malecontraceptive.org for questions regarding future opportunities.
MCI's Funding Mechanisms
External Funding Opportunities
Development of Novel Non-steroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
The purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary research approaches for the development of novel non-steroidal contraceptive products for men and women that act prior to fertilization. This FOA aims to position innovative and validated methods for future clinical development. Letter of intent due February 28, 2023, proposal due March 29, 2023.
The purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary research approaches for the development of novel non-steroidal contraceptive products for men and women that act prior to fertilization. This FOA aims to position innovative and validated methods for future clinical development. Letter of intent due February 28, 2023, proposal due March 29, 2023.
-------------------------
Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. Letter of intent due February 28, 2023, proposal due March 29, 2023.
This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. Letter of intent due February 28, 2023, proposal due March 29, 2023.
-------------------------
Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. High risk/high reward projects that lack preliminary data may be most appropriate for this FOA. Letter of intent due February 28, 2023, proposal due March 29, 2023.
This Funding Opportunity Announcement (FOA) invites grant applications to develop physiomimetic platforms and organoid culture systems for studies of the female reproductive tract and gametogenesis (both male and female) that can be used to uncover factors responsible for gynecological conditions and infertility. The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. High risk/high reward projects that lack preliminary data may be most appropriate for this FOA. Letter of intent due February 28, 2023, proposal due March 29, 2023.
